江西获批国内首个丝状真菌源微生物蛋白新食品原料

Core Insights - The National Health Commission of China has approved "Venetian Sclerotium Protein" as a new food ingredient, marking it as the first filamentous fungus-derived microbial protein approved in the country [1] - This approval signifies Jiangxi Province's advancement in the forefront of microbial protein development and represents a milestone for the "2030 Pioneer Project" focused on high-quality microbial protein manufacturing [1][3] Industry Overview - Traditional protein sources heavily rely on livestock farming, which struggles to meet the increasing demand due to population growth and rising living standards, leading to environmental pollution and resource waste [3] - Filamentous fungus-derived microbial protein offers a sustainable alternative with high manufacturing efficiency and lower carbon emissions, contributing to national protein supply security and supporting carbon neutrality goals [3] Company Developments - Jiangxi Fuxiang Pharmaceutical Co., Ltd. has established a pilot production line for microbial protein with a capacity of thousands of tons, and is advancing the construction of a large-scale production line with an expected annual output of 20,000 tons [5] - The projected annual output value after full production is anticipated to exceed 2 billion yuan [5] - The company has completed regulatory submissions for its microbial protein in major international markets, including the US, Singapore, and Europe, establishing a development framework of "Jiangxi R&D, International Standards, Global Promotion" [5] Future Plans - Jiangxi Fuxiang Pharmaceutical aims to accelerate the transformation of its core brand "Weiran Protein" into downstream products such as plant-based meat and protein beverages, creating a complete industrial chain from technological innovation to consumer application [5] - The goal is to foster a biomanufacturing industry cluster worth 10 billion yuan [5]